文献速递脑血管病外科神经重症

比较既往试验排除的破裂颅内动脉瘤血管内与外科治疗随机试验

A randomized trial comparing endovascular and surgical management of ruptured intracranial aneurysms excluded from previous trials.
PubMed 文献 · J Neurosurg · 2025-01-17

国际蛛网膜下腔动脉瘤试验-2将既往试验排除或代表性不足、仍考虑外科夹闭的破裂颅内动脉瘤患者随机分配至外科或血管内治疗,原计划1896例,实际6个中心纳入270例后因招募缓慢提前终止。1年死亡或依赖(mRS>2)外科组30% vs 血管内组27%(p=0.572);外科组残留动脉瘤更少但额外操作和住院>20天更多。

要点

  • 1年死亡或依赖:外科组30%(40/133)vs 血管内组27%(35/130),p=0.572。
  • 1年残留动脉瘤:外科组8%(10/118)vs 血管内组20%(22/109),p=0.015。
  • 住院>20天:外科组52%(69/133)vs 血管内组29%(38/130),p<0.001。

核心结论

  • 该提前终止的试验显示外科组额外操作更频繁、住院时间更长,但1年血管造影结果更好;1年死亡或依赖在血管内治疗与外科之间相似。

研究设计与样本

  • 国际蛛网膜下腔动脉瘤试验-2为随机试验,比较既往随机对照试验结果后仍考虑外科夹闭且也适合血管内治疗的破裂颅内动脉瘤患者接受外科还是血管内治疗。
  • 主要终点为1年时根据改良Rankin量表评分(mRS评分>2)定义的死亡或依赖;次要终点包括1年血管造影结果和住院时间。
  • 主要假设为血管内管理将把不良结局(mRS评分>2)从30%降至23%,所需样本量为1896例;试验因招募缓慢在10年后中断。
  • 主要分析按意向性治疗进行,未设盲。
  • 2012年11月至2022年12月,在6个北美和欧洲中心共招募270例患者;排除后263例随机分配至外科(n=133)或血管内治疗(n=130),有12例交叉(9例从外科转向血管内治疗)。

主要发现

  • 主要结局在外科组133例中40例达到(30%,95%CI 23%-38%),血管内治疗组130例中35例达到(27%,95%CI 20%-35%)(p=0.572)。
  • 1年残留动脉瘤外科组118例中10例(8%,95%CI 5%-15%),血管内治疗组109例中22例(20%,95%CI 14%-29%)(p=0.015)。
  • 额外操作(脑室引流和去骨瓣减压术,p<0.05)和住院>20天在外科组更频繁:外科组133例中69例(52%,95%CI 43%-60%),血管内治疗组130例中38例(29%,95%CI 22%-38%)(p<0.001)。

局限性

  • 试验因招募缓慢在10年后中断。
  • 主要分析按意向性治疗进行,未设盲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Many patients with ruptured intracranial aneurysms (RIAs) underrepresented or excluded from previous randomized controlled trials (RCTs) comparing surgery with endovascular treatment (EVT) are still considered for surgical clipping, but the best management of these patients remains unknown. METHODS: The International Subarachnoid Aneurysm Trial-2 was a randomized trial comparing surgical versus EVT of RIAs considered for surgical clipping, despite the results of previous RCTs, and also eligible for EVT. The primary endpoint was death or dependency according to the modified Rankin Scale score (mRS score > 2) at 1 year. Secondary endpoints included 1-year angiographic results and length of hospital stay. The primary hypothesis was that endovascular management would decrease the number of poor outcomes (mRS score > 2) from 30% to 23%, necessitating 1896 patients. The trial was interrupted after 10 years because of slow recruitment. Primary analysis was by intent-to-treat. There was no blinding. RESULTS: From November 2012 to December 2022, 270 patients were recruited at 6 North American and European centers. After exclusions, 263 patients were randomly allocated to receive surgery (n = 133) or EVT (n = 130). There were 12 crossovers (9 from surgery to EVT). The primary outcome was reached in 40 of 133 surgical patients (30%, 95% CI 23%-38%) compared with 35 of 130 EVT patients (27%, 95% CI 20%-35%) (p = 0.572). Residual aneurysms at 1 year were less frequent with surgery (10/118 [8%, 95% CI 5%-15%]) than EVT (22/109 [20%, 95% CI 14%-29%]) (p = 0.015). Additional procedures (ventricular drainage and decompressive craniotomy, p < 0.05) and hospitalization > 20 days were more frequent in the surgery group (69/133 [52%, 95% CI 43%-60%]) than in the EVT group (38/130 [29%, 95% CI 22%-38%]) (p < 0.001). CONCLUSIONS: This prematurely interrupted trial showed more frequent additional procedures and longer hospitalizations but better 1-year angiographic results with surgery. The primary clinical outcome, death or dependency at 1 year, was similar for EVT and surgery.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Darsaut TE, Lecaros N, Comby PO, et al. A randomized trial comparing endovascular and surgical management of ruptured intracranial aneurysms excluded from previous trials. J Neurosurg. 2025. PMID: 39823597. doi:10.3171/2024.8.JNS241276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。